Article
Biochemistry & Molecular Biology
Jingjing Liu, Qi Zhang, Jiyu Wang, Changli Wang, Tian Lan, Tianyi Wang, Bing Wang
Summary: Knockdown of BAP31 in colorectal cancer cells enhances chemosensitivity to 5-FU and reduces stemness, potentially through the inhibition of the Wnt/beta-catenin signaling pathway.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Dentistry, Oral Surgery & Medicine
Yang Xiang, Lujie Si, Ying Zheng, Huiming Wang
Summary: This study explores the synergistic effect of shikonin on cisplatin against oral cancer. Shikonin inhibited oral cancer cell viability and enhanced the sensitivity of drug-resistant cells to cisplatin by regulating key proteins in cell proliferation and apoptosis-related pathways, with the most evident inhibitory effect observed on beta-catenin.
Article
Multidisciplinary Sciences
Yanlin Chen, Liping Yang, Yilu Qin, Shuiqing Liu, Yina Qiao, Xueying Wan, Huan Zeng, Xiaoli Tang, Manran Liu, Yixuan Hou
Summary: The study revealed that the cellular localization of JUP in gastric cancer is closely related to tumor progression and invasion, with a loss of membrane and/or cytoplasmic JUP exacerbating the malignancy, while the nuclear function of JUP in cooperation with B-catenin promotes gastric cancer cell invasion.
JOURNAL OF ADVANCED RESEARCH
(2021)
Article
Pharmacology & Pharmacy
Young Yun Jung, Jae-Young Um, Arunachalam Chinnathambi, Chandramohan Govindasamy, Acharan S. Narula, Ojas A. Namjoshi, Bruce E. Blough, Gautam Sethi, Kwang Seok Ahn
Summary: This study investigated the effects of Withaferin A (WFA) on apoptosis and autophagy in human colorectal cancer cells. The results showed that WFA could induce cell cycle arrest, increase apoptotic cell death, and activate autophagy. The WFA-induced effects on apoptosis and autophagy were mediated through the modulation of the beta-catenin pathway.
EUROPEAN JOURNAL OF PHARMACOLOGY
(2022)
Article
Oncology
Yunting Jian, Lingzhi Kong, Hongyi Xu, Yawei Shi, Xinjian Huang, Wenjing Zhong, Shumei Huang, Yue Li, Dongni Shi, Yunyun Xiao, Muwen Yang, Siqi Li, Xiangfu Chen, Ying Ouyang, Yameng Hu, Xin Chen, Libing Song, Runyi Ye, Weidong Wei
Summary: PPP1R14C is upregulated in TNBC and associated with poor prognosis. Overexpression of PPP1R14C promotes cell proliferation and the aggressive phenotype in TNBC cells, while depletion of PPP1R14C has the opposite effect. Additionally, phosphorylated PPP1R14C inhibits the phosphorylation of GSK3β and recruits E3 ligase TRIM25 for ubiquitylation and degradation of non-phosphorylated GSK3β.
CLINICAL AND TRANSLATIONAL MEDICINE
(2022)
Article
Biochemical Research Methods
Li Gao, Ying Lu, Hai-Ning Chen, Zhigui Li, Meng Hu, Rou Zhang, Xiuxuan Wang, Zhiqiang Xu, Yanqiu Gong, Rui Wang, Dan Du, Shan Hai, Shuangqing Li, Dan Su, Yuan Li, Heng Xu, Zong-Guang Zhou, Lunzhi Dai
Summary: This study found that the expression of GSK3 alpha, but not GSK30, was significantly correlated with the overall survival of colon cancer patients. Through analysis of its phosphorylation substrates and protein interactions, specific functions of GSK3 alpha in colon cancer were revealed, suggesting it as a potential therapeutic target.
MOLECULAR & CELLULAR PROTEOMICS
(2023)
Article
Dermatology
Kyung-Il Kim, Kyung Eun Jung, Young-Bin Shin, Chang-Deok Kim, Tae-Jin Yoon
Summary: In this study, we conducted a large-scale screening test on drugs approved for other diseases to find pigmentation-modulating agents. Among the potential drugs, sorafenib was selected for further investigation on its effect on pigmentation in melanoma cells. The results showed that sorafenib promoted pigmentation by increasing the melanin content and tyrosinase activity. Mechanistic studies revealed that this effect was mediated by the activation of beta-catenin signaling through the regulation of GSK3 beta phosphorylation.
EXPERIMENTAL DERMATOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Chien-Yu Huang, Po-Li Wei, Uyanga Batzorig, Precious Takondwa Makondi, Cheng-Chin Lee, Yu-Jia Chang
Summary: CRC is the second leading cause of cancer-related death, and identifying new therapeutic targets for CRC is essential. This study investigated the role of MSN in CRC progression and found that high MSN expression in CRC tissues was associated with poor patient outcomes. Further research revealed that MSN accelerated CRC progression via the beta-catenin-RUNX2 axis. These findings suggest that MSN holds potential as a new target for CRC treatment.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Biochemistry & Molecular Biology
Yao Zhang, Tingwang Shi, Yaohua He
Summary: The expression of GPR35 in bone marrow mesenchymal stem cells is suppressed in osteoporosis patients and mice, affecting osteogenic differentiation. GPR35 deficiency impairs the function of BMSCs, while overexpression contributes to osteogenesis. The synthetic GPR35 agonist zaprinast can reduce bone loss and promote bone generation, suggesting a potential novel treatment for osteoporosis.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
(2021)
Article
Integrative & Complementary Medicine
Jingming Zhuang, Jiahang Mo, Zhengnan Huang, Yilin Yan, Zeyi Wang, Xiangqian Cao, Chenkai Yang, Bing Shen, Fang Zhang
Summary: Using network pharmacology and in vitro experiments, this study tentatively elucidated the mechanism of Xiaozheng decoction against bladder cancer. The main active ingredients of Xiaozheng decoction, including quercetin, amygdalin, and borneol, were found to promote bladder cancer cell apoptosis and inhibit proliferation and migration through the Bcl-2/BAX and GSK3 beta/β-catenin pathways. These findings provide a scientific basis for future research.
Article
Oncology
Hongyan Li, Ning Zhang, Xueli Jiao, Cong Wang, Wenhao Sun, Yanyu He, Ganglin Ren, Shirui Huang, Mengjie Li, Yixin Chang, Zihui Jin, Qipeng Xie, Xiaodong Zhang, Haishan Huang, Honglei Jin
Summary: MiR-6125 is downregulated in CRC, negatively correlated with tumor size and prognosis. MiR-6125 targets YTHDF2, downregulates its protein, stabilizes m6A-modified GSK3 beta mRNA. Increased GSK3 beta protein inhibits Wnt/beta-catenin/Cyclin D1 pathway proteins, leading to G0-G1 phase arrest and inhibiting CRC cell proliferation.
CLINICAL AND TRANSLATIONAL MEDICINE
(2021)
Article
Oncology
Brittany A. Borden, Yasmine Baca, Joanne Xiu, Fabio Tavora, Ira Winer, Benjamin A. Weinberg, Ari M. Vanderwalde, Sourat Darabi, W. Michael Korn, Andrew P. Mazar, Francis J. Giles, Lorin Crawford, Howard Safran, Wafik S. El-Deiry, Benedito A. Carneiro
Summary: The study analyzed GSK-3β alterations in tumors, finding that most mutations occurred in the kinase domain, with uterine endometrioid carcinoma having the highest mutation rate. Moreover, tumors with GSK-3β mutations displayed a microenvironment with increased B cell infiltration and were associated with increased PD-L1 expression in certain tissues.
MOLECULAR CANCER THERAPEUTICS
(2021)
Article
Plant Sciences
Ge Wang, Lu Li, Yan Li, Li-Hong Zhang
Summary: This study aimed to investigate the effects of toosendanin (TSN) on cisplatin (DDP) resistance in ovarian cancer (OC) and explore the underlying molecular mechanism. The results showed that TSN could reduce the DDP resistance in OC by modulating the miR-195/ERK/beta-catenin pathway, suggesting its potential as an effective agent to overcome clinical DDP resistance in OC.
Article
Oncology
Xiao-man Dai, Yan-hui Zhang, Xiao-han Lin, Xiao-xing Huang, Yi Zhang, Chao-rong Xue, Wan-nan Chen, Jian-xin Ye, Xin-jian Lin, Xu Lin
Summary: SIK2 acts as a tumor suppressor in gastric cancer by inhibiting the AKT/GSK3 beta/beta-catenin signaling pathway and suppressing epithelial-mesenchymal transition. Reduced expression of SIK2 is associated with poor prognosis in patients with gastric cancer. These findings suggest that SIK2 may serve as a novel prognostic biomarker and therapeutic target for gastric cancer.
MOLECULAR ONCOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Eleonora Vecchio, Nancy Nistico, Gaetanina Golino, Enrico Iaccino, Domenico Maisano, Selena Mimmi, Annamaria Aloisio, Maurizio Renna, Angelica Avagliano, Alessandro Arcucci, Giuseppe Fiume, Ileana Quinto
Summary: The IBTK gene encodes the IBtk alpha protein, which plays a role in the regulation of MYC-dependent B-lymphomagenesis. Mechanistically, IBtk alpha indirectly activates the beta-catenin-dependent transcription of the MYC gene by modulating GSK3 beta. Silencing IBtk alpha leads to downregulation of MYC expression and increased apoptosis in Burkitt's lymphoma cells.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)